NATERA INC

NASDAQ: NTRA (Natera, Inc.)

Last update: 2 days ago, 5:58PM

322.10

56.72 (21.37%)

Previous Close 265.38
Open 320.90
Volume 3,360,266
Avg. Volume (3M) 1,481,516
Market Cap 46,129,672,192
Price / Sales 14.82
Price / Book 21.62
52 Weeks Range
149.38 (-53%) — 323.01 (0%)
Earnings Date 5 Nov 2026
Profit Margin -10.36%
Operating Margin (TTM) -15.78%
Diluted EPS (TTM) -1.47
Quarterly Revenue Growth (YOY) 36.50%
Total Debt/Equity (MRQ) 15.78%
Current Ratio (MRQ) 3.87
Operating Cash Flow (TTM) 153.12 M
Levered Free Cash Flow (TTM) 120.93 M
Return on Assets (TTM) -8.87%
Return on Equity (TTM) -18.66%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock Natera, Inc. Mixed Bullish

AIStockmoo Score

-1.5
Analyst Consensus NA
Insider Activity -5.0
Price Volatility -3.0
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average -1.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
NTRA 46 B - - 21.62
IDXX 45 B - 41.78 28.34
ILMN 29 B - 35.33 10.80
GH 23 B - - 55.67
MEDP 16 B - 34.75 37.09
ICLR 13 B - 252.66 1.35

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Growth
% Held by Insiders 3.24%
% Held by Institutions 96.37%

Ownership

Name Date Shares Held
Duquesne Family Office Llc 31 Mar 2026 3,063,606
Castle Hook Partners Lp 31 Mar 2026 2,529,810

No data within this time range.

Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BROPHY MICHAEL BURKES - 254.69 -5,064 -1,284,766
CHAPMAN STEVEN LEONARD - 255.13 -5,770 -1,468,033
FESKO JOHN - 255.13 -1,713 -436,596
MOSHKEVICH SOLOMON - 255.13 -2,214 -564,283
RABINOWITZ DANIEL - 255.13 -1,887 -481,075
RABINOWITZ MATTHEW - 258.03 -1,718 -443,296
SHEENA JONATHAN - 255.13 -479 -122,487
Aggregate Net Quantity -18,845
Aggregate Net Value ($) -4,800,536
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 255.24
Name Holder Date Type Quantity Price Value ($)
BROPHY MICHAEL BURKES Officer 29 Jul 2026 Automatic sell (-) 1,863 253.82 472,867
CHAPMAN STEVEN LEONARD Officer 28 Jul 2026 Automatic sell (-) 3,580 252.22 902,948
MOSHKEVICH SOLOMON Officer 28 Jul 2026 Automatic sell (-) 1,204 252.22 303,673
BROPHY MICHAEL BURKES Officer 28 Jul 2026 Automatic sell (-) 2,419 252.22 610,120
FESKO JOHN Officer 28 Jul 2026 Automatic sell (-) 931 252.22 234,817
SHEENA JONATHAN Director 28 Jul 2026 Automatic sell (-) 191 252.22 48,174
RABINOWITZ DANIEL Officer 28 Jul 2026 Automatic sell (-) 1,003 252.22 252,977
CHAPMAN STEVEN LEONARD Officer 27 Jul 2026 Automatic sell (-) 2,190 258.03 565,086
MOSHKEVICH SOLOMON Officer 27 Jul 2026 Automatic sell (-) 1,010 258.03 260,610
BROPHY MICHAEL BURKES Officer 27 Jul 2026 Automatic sell (-) 782 258.03 201,779
FESKO JOHN Officer 27 Jul 2026 Automatic sell (-) 782 258.03 201,779
SHEENA JONATHAN Director 27 Jul 2026 Automatic sell (-) 288 258.03 74,313
RABINOWITZ MATTHEW Officer 27 Jul 2026 Automatic sell (-) 1,718 258.03 443,296
RABINOWITZ DANIEL Officer 27 Jul 2026 Automatic sell (-) 884 258.03 228,099
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria